Literature DB >> 26786485

Mutation pattern in rifampicin resistance determining region of rpoB gene in multidrug-resistant Mycobacterium tuberculosis isolates from Pakistan.

Obaidullah Qazi1, Hazir Rahman2, Zarfishan Tahir3, Muhammad Qasim4, Sajid Khan4, Aftab Ahmad Anjum5, Tahir Yaqub6, Muhammad Tayyab6, Nawab Ali7, Sehrish Firyal6.   

Abstract

The current study was undertaken to characterize the RRDR rpoB gene mutations among the rifampicin-resistant Mycobacterium tuberculosis (MTB) isolates from Pakistan. Rifampicin mutation patterns were analyzed by using PCR followed by rpoB gene sequencing. Among the 1080 referred TB cases, 63 (6%) were resistant against at least one first-line TB drug. Out of these 63 resistant isolates, 24 isolates (38%) were found to be resistant to isoniazid and rifampicin. Sequence analysis of multidrug-resistant tuberculosis (MDR-TB) isolates detected a single mutation in the RRDR region of the rpoB gene at codon 531, 516, 512, 528 and 533; however, 5 MDR-TB isolates lack any mutation in the RRDR region. A double mutation was observed in 1 MDR-TB isolate at codon 512 and 516 which are reported for the first time from Pakistan. Moreover, in 1 isolate a novel silent mutation was observed at codon 528. Further studies about these mutations may be helpful in the development of diagnostic tools for the detection of MTB in a high TB endemic area like Pakistan.
Copyright © 2014 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multidrug-resistant isolates; Mycobacterium tuberculosis; RRDR rpoB gene mutations; Sequencing

Year:  2014        PMID: 26786485     DOI: 10.1016/j.ijmyco.2014.06.004

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  5 in total

1.  Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.

Authors:  Edgar Kigozi; George W Kasule; Kenneth Musisi; Deus Lukoye; Samuel Kyobe; Fred Ashaba Katabazi; Eddie M Wampande; Moses L Joloba; David Patrick Kateete
Journal:  PLoS One       Date:  2018-05-30       Impact factor: 3.240

2.  Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India.

Authors:  Anshika Narang; Kushal Garima; Shraddha Porwal; Archana Bhandekar; Kamal Shrivastava; Astha Giri; Naresh Kumar Sharma; Mridula Bose; Mandira Varma-Basil
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

3.  Electrochemical Detection of Single-Nucleotide Polymorphism Associated with Rifampicin Resistance in Mycobacterium tuberculosis Using Solid-Phase Primer Elongation with Ferrocene-Linked Redox-Labeled Nucleotides.

Authors:  Mayreli Ortiz; Miriam Jauset-Rubio; Vasso Skouridou; Diana Machado; Miguel Viveiros; Taane G Clark; Anna Simonova; David Kodr; Michal Hocek; Ciara K O'Sullivan
Journal:  ACS Sens       Date:  2021-11-19       Impact factor: 7.711

4.  Mutational Frequencies in Mycobacterial rpoB gene using GeneXpert/MTB Rif Assay in Rifampicin Resistant patients at a tertiary care setting in Urban Sindh, Pakistan: Analysis from a Five-Year Period.

Authors:  Muhammad Alamgir; Mehwish Sajjad; Mirza Saifullah Baig; Muhammad Yahya Noori
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

5.  Detection of mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains inhibiting wild type probe hybridization in the MTBDR plus assay by DNA sequencing directly from clinical specimens.

Authors:  Pallavi Sinha; G N Srivastava; Rajneesh Tripathi; Mukti Nath Mishra; Shampa Anupurba
Journal:  BMC Microbiol       Date:  2020-09-16       Impact factor: 3.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.